Related Experiment Video
Updated: Oct 7, 2026
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
Neonatal screening of phenylketonuria and congenital hypothyroidism in China
1Xin Hua Hospital, Shanghai Second Medical University, Shanghai Institute for Pediatric Research, China. xhkj@public.sta.net.cn
Insights
Neonatal screening in China, initiated in 1981, identified phenylketonuria and congenital hypothyroidism in over 1.1 million newborns. Despite low national coverage, major cities show high screening rates, highlighting regional disparities.
Area of Science:
- Preventive Medicine
- Neonatal Health
- Public Health Policy
Background:
- Mass screening of newborns for congenital metabolic diseases is a key advancement in preventive medicine.
- Neonatal screening in China commenced in 1981, with pilot studies conducted in major urban centers.
- Significant economic disparities across China present challenges for widespread neonatal screening implementation.
Purpose of the Study:
- To assess the incidence of specific congenital metabolic diseases in a large newborn population in China.
- To evaluate the progress and coverage of neonatal screening programs in China.
- To identify regional variations in neonatal screening implementation and outcomes.
Main Methods:
- Analysis of screening data from 1.1 million newborns across 8 major Chinese cities over a 6-year period.
- Calculation of incidence rates for phenylketonuria and congenital hypothyroidism.
- Comparison of national screening coverage rates with those in metropolitan areas.
Main Results:
- The incidence of phenylketonuria was determined to be 1/14,767.
- The incidence of congenital hypothyroidism was found to be 1/5,469.
- National neonatal screening coverage remains low at approximately 2%, while Shanghai achieved 95% coverage by 1997.
Conclusions:
- Neonatal screening is effective in identifying critical congenital metabolic diseases.
- Substantial regional disparities exist in China's neonatal screening coverage, influenced by economic factors.
- Efforts are needed to expand neonatal screening programs nationwide to address public health needs.
Abstract:
Mass screening of newborns for some congenital metabolic diseases is a tremendous achievement in the field of preventive medicine. The pilot study of neonatal screening in China was started in 1981. According to the results of 1.1 million newborn screenings from 8 big cities in the past 6 years, the incidence of phenylketonuria was 1/14,767 and congenital hypothyroidism was 1/5,469. China is a vast country with great economic differences among the different regions, making neonatal screening difficult in some areas. The national neonatal screening coverage rate is only about 2 % at the moment, but in metropolitan centers like Shanghai, the coverage rate reached 95 % in 1997.